Atlas Trials

A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.

Clinical trial NCT07060248 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07060248
Sponsor
Second Xiangya Hospital of Central South University
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Renal Cell Carcinoma (RCC)
Start date
2025-01-01
Primary completion
2027-06-30
Enrollment
700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.